ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNG Synairgen Plc

6.20
-0.30 (-4.62%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.30 -4.62% 6.20 5.52 6.48 6.00 6.00 6.00 197,722 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.68 12.08M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 6.50p. Over the last year, Synairgen shares have traded in a share price range of 4.20p to 10.62p.

Synairgen currently has 201,345,000 shares in issue. The market capitalisation of Synairgen is £12.08 million. Synairgen has a price to earnings ratio (PE ratio) of -0.68.

Synairgen Share Discussion Threads

Showing 251 to 272 of 98850 messages
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older
DateSubjectAuthorDiscuss
22/3/2020
14:30
Nobby, you're saying that it's not factual that AZ were about to take over Synairgen for $230 million 3 years ago?

Are you wanting to keep this low tomorrow so you can add more?

I think you'll be doing well to get in below 60p at the opening assuming it doesn't go straight into auction as it finished on Friday!

The last 10 mins on Friday the share price was on a massive overdose of viagra!!

With the seller cleared and a very tight free float this will be over a quid early this week.

likya123
22/3/2020
14:25
Not proven yet I'm afraid; there has not been a successful phase II reported to date. The COPD phase II trial will report shortly maybe before the Covid 19 one.

I am as bullish as anyone here but I really do want accurate information to be disseminated not ramping BS.

nobbygnome
22/3/2020
14:22
AZ wanted to take Synairgen for £230 million about 3 years ago.

Synairgen already have proven product for asthma/copd. This is no gamble, this is very undervalued and a once in a lifetime opportunity at anywhere near 50p!

What price with sucess with covid-19?

I'm guessing a billion would be way too low!!

That would be 20 x Friday's close..a cool £10 per share.

Makes sense why we're going to go bananas tomorrow!!

likya123
22/3/2020
14:13
But if anyone makes an offer now it would have to be say at least £150 million. That is a gamble for even a big Pharma. You have to think of it on an individual level. The BD guy or guys who come up with this proposal and champion it is/are putting their careers on the line for a binary bet. I have been there and that is very unlikely to happen I can assure you.
nobbygnome
22/3/2020
13:57
Nobby - it would not be a massive gamble when the Company has a MC of 50m or even 500m.

At the very least I expect to see some strategic stake building here by Majors be it directly or arms length, as well as Government owned funds.

talk2dubya
22/3/2020
13:23
PDT taken from the dailymail article

A smaller British firm called Synairgen – which was previously a partner of AstraZeneca – is this week starting human trials to test if its existing lung treatment will help patients who have contracted Covid-19.

If the results come back positive, the company hopes to be able to start treating patients within the next year.

The pilot phase, beginning this week, will last two months and will involve 100 patients – half of which will be given placebos while the remainder take the potential treatment.
If the results are positive, the company will begin a larger human 'pivotal' trial.

Richard Marsden, chief executive of the AIM-listed company, said he is convinced that getting a treatment ready for widespread use within a year is 'feasible'.

In normal circumstances these trials take several years to complete.

'There might be two or three drugs which produce positive data over the next eight weeks,' Marsden told The Mail on Sunday. 'If we get good data and it's well tolerated, I would expect governments to be under pressure to want to talk to us about larger supplies of the drug.'

Marsden hailed the authorities for giving his company fast-track approval for its test medication which it is also hoping will treat asthma and the lung condition known as COPD.

bmnsa
22/3/2020
13:13
A smaller British firm called Synairgen – which was previously a partner of AstraZeneca – is this week starting human trials to test if its existing lung treatment will help patients who have contracted Covid-19.
tidy 2
22/3/2020
12:58
I think news of SNG's work is starting to get out there. The Mail On Sunday article today has been shared on social media 565 times. Other stories in the same section of their website are less than 10 shares.
pdt
22/3/2020
12:01
Nobby,

Told you they were a bit sensitive on 'tother' thread....

yet another final
22/3/2020
11:51
Just seen the UK Stockchallenge for 2020, only a handful of entries are blue and the top 3 entries all hold SNG !
donsan
22/3/2020
11:47
Lauders - thank you!

AZN may regret that:)

toffeeman
22/3/2020
11:36
Virtually no chance of a takeover now IMHO. A collaboration with a major Pharma is much more likely. In the future that might lead to a takeover but it ain't going to happen now. Contrary to popular opinion, major Pharma don't gamble....and with a binary event coming up in 2 months or so,this would be a massive gamble!
nobbygnome
22/3/2020
11:09
This news release will answer your question Toffeeman:
lauders
22/3/2020
11:04
So what actually is the status of the agreement made some years ago with AZN?

Could AZN insist on the original terms, or is SNG free to start afresh with them or other big Pharma?

There will not be a fund raise - it's a case of doing a deal with major(s) with production capacity, not something SNG should do!

toffeeman
22/3/2020
10:44
Fantastic post from lse board..


John117, I agree the AZN $230m deal refers to a previous deal. A new deal would not be in place yet. It would be by default much higher given market reach for COPD and SARS strains. The questions on my mind are these...

How could AZN now do a $230m deal with SNG for a market worth potentially billions. SNG wouldn’t. It would severely undervalued them. Any deal would be incremental with value points for SNG.

Why would AZN do a deal in hundreds on millions for an AIM co with a MCAP of £48m? They may but it don’t make sense..

What is the downside risk for AZN if they take out SNG now? SNG001 clinical trials fail, but they have not wasted their money due to other products and asthma/COPD application.

What is the downside risk if AZN wait for trials to finish. If they fail they can carry on as is but if they are statically dominant over the double blind placebo in 100 pts then SNG name their price so AZN will have to buy. But then enter the twist. What if success flushes out another buyer?

Mmm think this through. It’s AZN that have all the puzzles to solve. Personally I’d value SNG now add on a big premium and buy because there is value, they have the money, SNG sits in AZN business model and they really don’t want to go to a bidding war and loose SNG.

No doubt there will be many more twists in the board rooms than in the theatres. All imo.

likya123
22/3/2020
10:42
Nobby,
valid point re Fund raising....it should not matter to anyone who believes in this company. We all invested cos we believe the share price will fly (50%, 100%, 200% watever..)

Its only greed or fear that upsets investors when there is any form of 'dilution'. If this company was going about its work in a normal fashion, then all will be fearful of their shares being diluted. When a share price is rising, greed kicks in when dilution occurs, "cos I would have made more". (akin to investors who set their desired "entry Price" to buy a share, and if it is above that, they refuse to buy ---- in the end, it does not matter if you believe the share will motor)....

This is not the case with SNG....this co is on the verge of a major breakthrough in managing the Covid crisis (other companies are as well---for a balanced opinion)

I personally believe if successful, they will announce a partnership with a Major, and my money is on AZ

Cant wait till tomorrow am.
GLA

yet another final
22/3/2020
10:32
Likya as I posted yesterday that comment of 61m shares is inaccurate it is only 49m shares that are in public hands and over 20m shares were traded in the last 2 days so assuming half wets sells that only leaves 39m in public hands prior to Thursday.Of course people can trade multiple times.It all points to a large share price rise!
dave444
22/3/2020
10:08
The inhalers are readily available and used already in the general population of those with respiratory issues
dave444
22/3/2020
09:47
Yes I just think it is better to prepare everyone for this possibility. Personally I would see any pullback after a fund raise is announced as a buying opportunity. However, that is definitely not why I am talking about this. It is all about awareness. In an ideal world I would rather they didn't dilute my holding.
nobbygnome
22/3/2020
09:44
Stick to your guns, nobby. I would go further.
freedosh
22/3/2020
09:39
I agree. People are so sensitive if you post anything even vaguely seen as negative. As I keep on saying I actually don't see small fund raises as negative anyway. Ho hum...
nobbygnome
22/3/2020
09:30
Easy to get distracted and territorial over shares and news.

The main topic here is SNG but clearly,as it involves the Coronavirus, it cannot help but reference other firms.
They don't seem to be competing to me,as they are covering a different angle,so those that knock them are misled I believe.

Let's pull together!

hazl
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older

Your Recent History

Delayed Upgrade Clock